Mkts

Monte Rosa Therapeutics, Inc.

NASDAQ: GLUE
$10.57+0.32 (+3.12%)
As of Nov 6, 4:00 PM ET

Key statistics

Day range
9.8810.67
52-week range
9.6825.77
Today
Open10.30
Previous close10.57
Volume545.1K
Valuation
Market cap901.76M
P/E ratio—
EPS (TTM)-1.74
Income & risk
Dividend / yield—
Beta1.36
Avg volume1.36M
Discussion

GLUE News

Stories mentioning GLUE from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue
Cost of Goods Sold
Gross Profit0.000.000.000.000.000.000.000.00
Operating Expenses
Research & Development44,06941,97936,67830,65332,19038,86627,61628,055
Sales General & Admin
Total Operating Expenses54,24452,49645,74338,74840,89347,64335,74337,337
Operating Income (Loss)(50,034)(49,715)(32,975)(15,554)44,03613,004(26,527)(32,642)
Interest Income
Interest Expense
Other Expense
Pretax Income(44,451)(46,076)(30,258)(11,096)47,70715,601(23,788)(30,058)
Tax Provision52.0059.00(3,177)1,199822.002,16471.00252.00
Net Income (Loss)(44,503)(46,135)(27,081)(12,295)46,88513,437(23,859)(30,310)
Earnings Per Share (Basic)(0.56)0.18
Earnings Per Share (Diluted)(0.56)0.18
Weighted Average Shares Outstanding (Basic)99,88483,07182,39882,18782,14973,91082,01271,234
Weighted Average Shares Outstanding (Diluted)99,88483,07182,39882,18782,95673,91082,01271,234

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About GLUE

Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE) is a stock listed on the Nasdaq Stock Market under the ticker symbol GLUE. It last traded at $10.57 (Nov 6, 2026, 4:00 PM ET), up 3.1% on the day. That gives Monte Rosa Therapeutics a market capitalisation of $901.8M.

Over the past 52 weeks GLUE has traded between $9.68 and $25.77.

For the quarter ended Mar 31, 2026 it reported a net loss of $44.5M.

Last 4 quarters
Quarter endedRevenueNet income
Mar 31, 2026—-$44.5M
Dec 31, 2025—-$46.1M
Sep 30, 2025—-$27.1M
Jun 30, 2025—-$12.3M

From Monte Rosa Therapeutics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…